Results 131 to 140 of about 97,084 (281)

Trends in Endoscopist Reporting Rates of Eosinophilic Gastrointestinal Diseases in Japan Evaluated by the Japan Endoscopy Database Project

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
We analyzed 9,940,870 endoscopic procedures from the Japanese Endoscopy Database (2015–2023), identifying 9,669 eosinophilic gastrointestinal disease (EGID) cases. The prevalence of eosinophilic esophagitis, gastritis, and duodenitis increased significantly (p < 0.001), while enteritis and colitis remained unchanged (p = 0.136). EoE rose from 36 cases (
Kazuya Miyaguchi   +4 more
wiley   +1 more source

Successful Treatment of Refractory IgA‐Mediated Autoimmune Hemolytic Anemia With Bortezomib

open access: yeseJHaem, Volume 6, Issue 6, December 2025.
ABSTRACT Introduction IgA‐mediated autoimmune hemolytic anemia (AIHA) is a rare condition associated with severe hemolysis and limited therapeutic response. Bortezomib, a proteasome inhibitor, targets plasma cells responsible for autoantibody production.
Silvia Neri   +8 more
wiley   +1 more source

Characterization of Second‐Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry

open access: yesACR Open Rheumatology, Volume 7, Issue 11, November 2025.
Objective We performed a real‐world characterization of patients with rheumatoid arthritis (RA) who initiate a JAK inhibitor (JAKi) and switch to a subsequent therapy and examination of factors associated with the use of another JAKi/therapy with another mechanism of action (MoA).
Joshua F. Baker   +8 more
wiley   +1 more source

Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience

open access: yesAmerican Journal of Hematology, Volume 100, Issue 11, Page 1963-1971, November 2025.
ABSTRACT Breakthrough hemolysis (BTH) is defined as a hemolytic exacerbation in a patient with paroxysmal nocturnal hemoglobinuria (PNH) treated with complement inhibitors (CIs). In the current era of several terminal and proximal inhibitors, there are no guidelines for defining BTH and its severity, and clinical management is not standardized.
Bruno Fattizzo   +23 more
wiley   +1 more source

Gastroenteritis in infancy [PDF]

open access: yesBMJ, 1984
J A Walker-Smith   +2 more
openaire   +3 more sources

Exploring Transient Acute Respiratory Distress in Cholera: A Case Series

open access: yesClinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT Transient acute respiratory distress is a complication of cholera that is not fully understood, even though there are plausible theoretical explanations. Clinicians managing cholera outbreaks need to be aware of this phenomenon in order to manage it appropriately, while further studies are required for a holistic understanding and possible ...
Samuel Amo‐Tachie
wiley   +1 more source

Gastric Mucosal Biopsy in Eosinophilic (Allergic) Gastroenteritis

open access: bronze, 1977
Aubrey J. Katz   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy